Pharmaceutical Business Review - EntreMed has revealed that an an independent Data Safety Monitoring Board has conducted a favorable review of safety data from its breast cancer drug. The review was undertaken to assess the safety of the drug, MKC-1 in a phase II trial in patients
Online Press Release
PRWeb - Black Drivers Stripped of Civil Rights in New Jersey New Jersey prisons slammed with $2 million federal lawsuit for arrest Mesothelioma.com Finds Proposed Asbestos Bill is Taking Away Veterans’ Rights A Mesothelioma.com review of Asbestos Bill S.852
Eric Kinney, President
PRWeb - SF Jury Finds Chrysotile Asbestos Causes Rare Peritoneal Mesothelioma A jury awarded over $1.9 million to a 71 year old retired sheet metal worker who developed peritoneal mesothelioma from his prior on the job exposure to asbestos. - 2005-11